IRIDIUM WORLD C. A DL-,01 Aktie

Cathie Woods' ARK ETFs carried out extensive rebalancing on June 10: the largest sales were 186,720 shares of Iridium and 89,915 shares of Robinhood, along with a significant exit from Veracyte. At the same time, ARK increased its position in Kodiak AI by buying 141,502 shares. Other smaller sales included Roku, Twist Bioscience, Strata Critical Medical and 10X Genomics. The transactions are part of an ongoing reweighting of ARK portfolios toward prioritized innovation names. » Plus sur de.investing.com

Iridium reported Q1 2026 service revenue up 2% and OIBDA of $116.3 million, down 5% largely due to a shift to cash annual incentive compensation. Management reaffirmed full-year guidance (service revenue flat to +2%; operational OIBDA $480–490 million), highlighted cash of $111.6 million and net leverage of 3.4x, and projected pro forma free cash flow of about $318 million for 2026. New product catalysts include the TriMode Iridium 9,604 IoT module (commercial availability targeted in June), a PNT ASIC rolling out in July with a $100 million revenue target by 2030, and the standards-based Iridium NTN Direct service slated for commercial launch later this year. Company emphasized expanding government (EMSS/SDA) and aviation safety work, continued investment in growth vectors, and an ongoing dividend program. » Plus sur finance.yahoo.com

Iridium Communications shares hit a 52-week low of USD 19.89 and show oversold signals according to the RSI, despite solid metrics such as a current ratio of 2.51 and positive free cash flow. For the second quarter Iridium reported EPS of USD 0.20, missing the consensus of USD 0.24, while revenue of USD 216.9 million was slightly above expectations. BWS Financial downgraded the stock from neutral to sell and cut the price target from USD 25.00 to USD 16.00, citing Starlink’s acquisition of EchoStar spectrum licenses as a threat to Iridium’s business model. » Plus sur de.investing.com